Who Paid My Doc
Jacob Bonola
Dentist, Dental Public Health Marshall, TX Doctor of Dentistry
NPI 1497479877 CMS profile 11394295
100 Forrest Ter, Marshall, TX 75670
General payments
$6
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Jacob Bonola of Marshall, TX is reported in the CMS Open Payments database as having received $6 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 1st percentile of Dentist, Dental Public Health profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $6 | 1 |
Beside peers
- Jacob Bonola
- Dentist, Dental Public Health median
- Middle half of Dentist, Dental Public Health
- National median
In program year 2025, general payments to Jacob Bonola were reported at $0. Among 211 Dentist, Dental Public Health profiles paid that year, the median was $71 and the middle half received between $25 and $180.
Show as a table
| Year | Jacob Bonola | Dentist, Dental Public Health median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $55 | $23–$140 | $163 |
| 2020 | $0 | $60 | $20–$127 | $114 |
| 2021 | $0 | $72 | $28–$162 | $132 |
| 2022 | $0 | $52 | $19–$180 | $149 |
| 2023 | $6 | $52 | $20–$146 | $160 |
| 2024 | $0 | $67 | $25–$186 | $164 |
| 2025 | $0 | $71 | $25–$180 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 3 drugsPart D claims
55
Drug cost
$235
Branded share of claims
30.9%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Methylprednisolone | Generic | 17 | $96 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 17 | $92 | |
| Amoxicillin | Generic | 21 | $47 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 110,731 Part D prescribers listed as Dentist; they describe a distribution and say nothing about conduct.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Dentist, Dental Public Health in Texas
Codi Astiasaran
Dentist, Dental Public Health · Cross Plains, TX
Husain Kapadia
Dentist, Dental Public Health · Houston, TX
Anita Jhangiani
Dentist, Dental Public Health · Houston, TX
Jean Sanders
Dentist, Dental Public Health · Dallas, TX
Tania Arthur
Dentist, Dental Public Health · Houston, TX
Aaron Straw
Dentist, Dental Public Health · Houston, TX
Related records
Dentist, Dental Public Health in Texas
Practitioners in the same specialty and state, ranked by reported value.
All Dentist, Dental Public Health
Everyone recorded under this specialty, nationwide.
Doctors in Texas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.